Clinical Trial Update: A Healthy Volunteer And Patient Study To Assess The Safety, Tolerability And Pharmacokinetics Of GSK1265744 [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the safety, tolerability, and pharmacokinetics of GSK1265744 (cabotegravir) in healthy volunteers and HIV patients; the trial is comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• GSK1265744 (cabotegravir) (cabotegravir)

Snippet

Sponsor: GlaxoSmithKline | Conditions: HIV Infection | Phase 1 | Status: COMPLETED